Show simple item record

dc.contributor.authorCusters, JAE
dc.contributor.authorDavis, L
dc.contributor.authorMessiou, C
dc.contributor.authorPrins, JB
dc.contributor.authorvan der Graaf, WTA
dc.date.accessioned2021-07-02T11:24:19Z
dc.date.available2021-07-02T11:24:19Z
dc.identifier.citationCancer medicine, 2021, 10 (9), pp. 2943 - 2945
dc.identifier.issn2045-7634
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4670
dc.identifier.eissn2045-7634
dc.identifier.eissn2045-7634en_US
dc.identifier.doi10.1002/cam4.3889
dc.identifier.doi10.1002/cam4.3889en_US
dc.description.abstractFrequency of scanning has accelerated in the era of personalized medicine and is related, but not restricted, to the exploding number of clinical trials for new cancer treatments. Particularly in drug trials, but also in clinical practice, patients are followed up by scans frequently, which may vary from every 6 to 12 weeks until progression. The authors aimed to raise awareness for this underreported but widely present "Sword of Damocles" scan-related issue also referred to as 'scanxiety.'
dc.formatPrint-Electronic
dc.format.extent2943 - 2945
dc.languageeng
dc.language.isoeng
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleThe patient perspective in the era of personalized medicine: What about scanxiety?
dc.typeJournal Article
dcterms.dateAccepted2021-05-01
rioxxterms.versionVoR
rioxxterms.versionofrecord10.1002/cam4.3889
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
dc.relation.isPartOfCancer medicine
pubs.issue9
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR
pubs.publication-statusPublished
pubs.volume10en_US
pubs.embargo.termsNot known
dc.contributor.icrauthorMessiou, Christinaen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/